Influence of growth hormone binding protein on growth hormone estimation in different immunoassays

REFERENCES

• Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC. A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 1986; 62: 134 — 41.
   Google Scholar
• Herington AC, Ymer S, Stevenson J. Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 1986; 77: 1817 — 23.
   Google Scholar
• Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, etal. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987; 330: 537–43.
   Google Scholar
• Baumann G, Mercado M. Growth hormone-binding proteins in plasma. Nutrition. 1993; 9: 546— 53.
   PubMedGoogle Scholar
• Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G. Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications [published errata appear in J Clin Invest 1993 May; 91(5): following 2334 and 1993 Aug; 92(2): follow-ing 1108]. J Clin Invest 1993; 91: 629–41.
   Google Scholar
• Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. Enhanced sensitiv-ity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concen-trations in men than women. J Clin Endocrinol Metab 1994; 78: 1312— 19.
   Google Scholar
• Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K. Growth-hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 1997; 43: 950 — 6.
   Google Scholar
• Jan T, Shaw MA, Baumann G. Effects of growth hormone-binding proteins on serum growth hor-mone measurements. J Clin Endocrinol Metab 1991; 72: 387–91.
   Google Scholar
• Strasburger CJ, Wu Z, Pflaum CD, Dressendorfer RA. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endo-crinol Metab 1996; 81: 2613 — 20.
   PubMedGoogle Scholar
• Orskov H, Thomsen HG, Yde H. Wick chromato-graphy for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968; 219: 193–5.
   Google Scholar
• Hansen BS, Hjorth S, Welinder BS, Skriver L, De Meyts P. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology 1993; 133: 2809 — 17.
   Google Scholar
• Fisker S, Frystyk J, Skriver L, Vestbo E, Ho KKY, Orskov H. A simple, rapid immunometric assay for determination of functional and growth hor-mone (GH)-occupied GH-binding protein in human serum. Eur J Clin Invest 1996; 26: 779— 85.
   PubMedGoogle Scholar
• Baumann G, Shaw MA, Buchanan TA. In vivo kinetics of a covalent growth hormone-binding protein complex. Metabolism 1989; 38: 330 — 3.
   Google Scholar
• Amit T, Barkey RJ, Youdim MB, Hochberg Z. A new and convenient assay of growth hormone-binding protein activity in human serum. J Clin Endocrinol Metab 1990; 71: 474 — 80.
   PubMedGoogle Scholar
• Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y. Measurement of free insulin-like growth factor-I using immunoradio-metric assay. J Immunoassay 1994; 15: 263–76.
   PubMedGoogle Scholar
• Reiter EO, Morris AH, MacGillivray MH, Weber D. Variable estimates of serum growth hormone concentrations by different radioassay systems. J Clin Endocrinol Metab 1988; 66: 68 — 71.
   PubMedGoogle Scholar
• Herington AC, Jacobs LS, Daughaday WH. Radio-receptor and radioimmunoassay quantitation of human growth hormone in acromegalic serum: overestimation by immunoassay and systematic differences between antisera. J Clin Endocrinol Metab 1974; 39: 257 — 62.
   Google Scholar
• Andersson AM, Orskov H, Ranke MB, Shalet S, Skakkebaek NE. Interpretation of growth hor-mone provocative tests: comparison of cut — off values in four European laboratories. Eur J Endo-crinol 1995; 132: 340 — 3.
   Google Scholar
• Celniker AC, Chen AB, Wert RMJ, Sherman BM. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469–76.
   PubMed Web of Science ®Google Scholar
• Levin PA, Chalew SA, Martin L, Kowarski AA. Comparison of assays for growth hormone using monoclonal or polyclonal antibodies for diagnosis of growth disorders. J Lab Clin Med 1987; 109: 85 — 8.
   PubMedGoogle Scholar
• Barth JH, Smith JH, Clarkson P. Wide diversity in measurements of growth hormone after stimula-tion tests in short children are due to assay variabil-ity. Ann Clin Biochem 1995; 32: 369–72.
   Google Scholar
• Roelen CA, Koppeschaar HP, de Vries WR, Zelissen PM, Snel YE, Doerga ME, etal. High-affi-nity growth hormone binding protein, insulin-like growth factor I and insulin-like growth factor bind-ing protein 3 in adults with growth hormone defi-ciency. Eur J Endocrinol 1996; 135: 82 — 6.
   Google Scholar
• Rajkovic IA, Valiontis E, Ho KK. Direct quantita-tion of growth hormone binding protein in human serum by a ligand immunofunctional assay: com-parison with immunoprecipitation and chromato-graphic methods. J Clin Endocrinol Metab 1994; 78: 772–7.
   Google Scholar
• Davila N, Alcaniz J, Salto L, Estrada J, Barcelo B, Baumann G. Serum growth hormone-binding pro-tein is unchanged in adult panhypopituitarism. J Clin Endocrinol Metab 1994; 79: 1347 — 50.
   PubMedGoogle Scholar
• Horikawa R, Tanaka T, Katsumata N, Satoh M, Nagashima A, Watanabe T, et al. Clinical signifi-cance of growth hormone-binding protein measurements in children. Proc Soc Exp Biol Med 1994; 206: 320 — 3.
   PubMedGoogle Scholar
• Luthman M, Stock S, Werner S, Bremme K. Growth hormone-binding protein in plasma is inversely correlated to placental lactogen and aug-mented with increasing body mass index in healthy pregnant women and women with gestational dia-betes mellitus. Gynecol Obstet Invest 1994; 38: 145 — 50.
   PubMedGoogle Scholar
• Carlsson L, Mercado M, Baumann G, Stene M, Attie K, Reichert M, et al. Assay systems for the growth hormone-binding protein. Proc Soc Exp Biol Med 1994; 206: 312— 15.
   Google Scholar
• Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding pro-tein-3, insulin, and growth hormone. Metabolism 1994; 43: 315 — 19.
   Google Scholar
• Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361 —9.
   PubMedGoogle Scholar